Log In
BCIQ
Print this Print this
 

VB6-845d

  Manage Alerts
Collapse Summary General Information
Company Eleven Biotherapeutics Inc.
DescriptionTargeted protein therapeutic consisting of an EpCAM targeting Fab genetically linked to deBouganin
Molecular Target Epithelial cell adhesion molecule (EpCAM)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat EpCAM-positive solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$36.0M

0

$22.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/21/2016

$36.0M

0

$22.5M

Get a free BioCentury trial today